Top Banner
December 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center Physical Address: 5-12315 Scott Research Tower Fred & Pamela Buffett Cancer Center 986858 Nebraska Medical Center Omaha, NE 68198-6858 EDUCATION Aug. 2002 – Dec. 2006 Doctor of Philosophy Pharmaceutics and Pharmaceutical Chemistry University of Utah Salt Lake City, UT Dissertation: Biodegradable Macromolecular Contrast Agents for Magnetic Resonance Imaging. (Defended Sept. 28, 2006) Mentor: Dr. Zheng-Rong Lu, Ph.D. Aug. 1998 – May 2002 Bachelor of Arts Chemistry (Biology concentration) Saint John’s University/College of Saint Benedict Collegeville, MN Undergraduate Research: Bidentate nitrogenous molybdenum complexes as catalysts. Mentor: Dr. Chris Schaller, Ph.D. POSTDOCTORAL TRAINING Oct. 2006 – July 2011 Postdoctoral Fellowship Biomedical Engineering Emory University–Georgia Institute of Technology Atlanta, GA Research Emphasis: Nanotechnology for Biomedical Imaging Applications Mentor: Dr. Shuming Nie, Ph.D. ACADEMIC APPOINTMENTS 2015 – Present Assistant Professor (Tenure-Track), Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center
23

Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

Apr 26, 2018

Download

Documents

tranminh
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

1

AaronMichaelMohs,Ph.D.DepartmentofPharmaceuticalSciencesCollegeofPharmacyUniversityofNebraskaMedicalCenter

PhysicalAddress:5-12315ScottResearchTowerFred&PamelaBuffettCancerCenter986858NebraskaMedicalCenterOmaha,NE68198-6858EDUCATIONAug.2002–Dec.2006 DoctorofPhilosophy PharmaceuticsandPharmaceuticalChemistry UniversityofUtah SaltLakeCity,UT Dissertation:BiodegradableMacromolecularContrastAgentsfor

MagneticResonanceImaging.(DefendedSept.28,2006) Mentor:Dr.Zheng-RongLu,Ph.D.

Aug.1998–May2002 BachelorofArts Chemistry(Biologyconcentration) SaintJohn’sUniversity/CollegeofSaintBenedict Collegeville,MN UndergraduateResearch:Bidentatenitrogenousmolybdenum

complexesascatalysts. Mentor:Dr.ChrisSchaller,Ph.D.

POSTDOCTORALTRAININGOct.2006–July2011 PostdoctoralFellowship BiomedicalEngineering EmoryUniversity–GeorgiaInstituteofTechnology Atlanta,GA ResearchEmphasis:NanotechnologyforBiomedicalImaging

Applications Mentor:Dr.ShumingNie,Ph.D.

ACADEMICAPPOINTMENTS2015–Present AssistantProfessor(Tenure-Track),DepartmentofPharmaceuticalSciences,

CollegeofPharmacy,UniversityofNebraskaMedicalCenter

Page 2: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

2

2015–Present CourtesyAssistantProfessor,BiochemistryandMolecularBiology,CollegeofMedicine,UniversityofNebraskaMedicalCenter

2015–Present Member,TheFredandPamelaBuffettCancerCenter,UniversityofNebraskaMedicalCenter

2015–Present Member,CenterforDrugDeliveryandNanomedicine,UniversityofNebraskaMedicalCenter

2015–2016 AdjunctAssistantProfessor,BiomedicalEngineering,WakeForestUniversityHealthSciences

2011–2015 AssistantProfessor(Tenure-Track),BiomedicalEngineering(primary),CancerBiology(joint),andRegenerativeMedicine(joint),WakeForestUniversityHealthSciences,WakeForestUniversity–VirginiaTechSchoolofBiomedicalEngineeringandSciences(SBES-WFUHS)

CERTIFICATESANDLICENCESNone.

GRANT/CONTRACTSUPPORTCurrentFundingTitle: TunableFluorescentOrganicNanoparticlesforCancerImaging

Applications.FundingAgency: NIH/NCIMechanism: R21CA212500Dates: 02/15/2017–01/31/2020TotalDollars: $602,000($400,000direct)Investigators: PI:Mohs;co-I:Dr.TonyHollingsworth

Title: NonclinicaldevelopmentofNervelight,anintra-operativeperipheralnerveimagingagent.

FundingAgency: NIH/NCIMechanism: R44CA180745Dates: 09/25/2017–08/31/2019TotalDollars: $1,972,209;$509,856toUNMC($336,785direct);contractinprocessInvestigators: sub-PI:Mohs;PI:ManzanitaPharmaceuticals(Dr.StephenKahl)

Title: HyaluronicAcidBasedNanoparticlesforTargetedImage-GuidedTumorSurgery.

FundingAgency: NIH/NIBIBMechanism: R01EB019449Dates: 09/25/2014–06/30/2018TotalDollars: $1,325,018($895,500direct)Investigators: PI:Mohs;co-I:Drs.FrankC.MariniandGracaAlmeida-Poroda

Page 3: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

3

Title: NanoparticleFormulationsofOrlistatforTreatmentofChemoresistantCancer.

FundingAgency: NIH/NIGMSMechanism: ProjectunderP20GM103480(COBRE:NebraskaCenterfor

Nanomedicine.)Dates: 06/01/2016–05/31/2018TotalDollars: $250,000directInvestigators: ProjectPI:Mohs

Title: PositionstoSupporttheNationalStrategicResearchInstitute.FundingAgency: NebraskaResearchInitiativeDates: 01/01/2016–12/31/2018TotalDollars: $375,550directInvestigators: PI:Mohs

Title: MultimodalContrastAgentsforIntegratedPreoperativeandIntraoperativeImagingofPancreaticCancer.

FundingAgency: Cattlemen'sBallAssociationofNebraskaMechanism: UNMCPancreaticSPOREDevelopmentalResearchProjectDates: 09/01/2016–08/31/2017(continuedunderno-costextension)TotalDollars: $50,000directInvestigators PI:Mohs;co-I:Dr.YutongLiu(formerco-I:Dr.MichaelBoska)

Title: Developmentofcontrastagentstargetingtolymphangiogenesisinanorthotopicprostatecancermodel.

FundingAgency: DepartmentofUrologyviaDaviesPhilanthropyDates: 06/01/2016–05/31/2017(continuedunderno-costextension)TotalDollars: $50,000directInvestigators: PI:Mohs;co-PI:Dr.SamikshanDutta;co-I:Drs.KaustubhDattaandChad

LaGrange

Title: NanomedicineApproachestoImage-GuidedDrugDeliveryinMetastaticCancers.

FundingAgency: UNMCCollegeofPharmacyMechanism SeedGrantFundsDates: 07/01/2017–06/30/2018TotalDollars: $90,000directforallPIscombinedInvestigators: co-PIs:Drs.Mohs,JeredGarrison,DJMurry,andDavidOupicky

CompletedFundingTitle: Nanotechnologyforminimallyinvasiveforcancerdetectionand

resection.FundingAgency: NIH/NCIMechanism: K99/R00PathwaytoIndependenceAwardinCancerNanotechnology

Research;K99/R00CA153916

Page 4: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

4

Dates: 09/03/2010–03/31/2017TotalDollars: $894,259($654,711direct)K99andR00phasescombinedInvestigators: PI:Mohs

Title: Longitudinalassessmentsofplacentaloxygenationandperfusionusingultrasoundandphotoacoustics.

FundingAgency: NIH/NICHDMechanism: R21HD086357Dates: 09/17/2015–8/31/2017TotalDollars: $45,690($30,359direct)Investigators: PI:Dr.Yamaleyeva(subcontractPI:Mohs)

Title: Multimodalcontrastagentsforpreoperativeandintraoperativeimaging.

FundingAgency: NebraskaDepartmentofHealthandHumanServicesMechanism: LB5062017-41Dates: 07/01/2016–06/30/2017TotalDollars: $50,000Investigators: PI:Mohs

Title: DevelopmentofMultimodalImagingNanoparticlesforIntegratedPreoperativeandIntraoperativeImaging.

FundingAgency: NebraskaCenterforNanomedicineMechanism: ImagingRelatedPilotGrantsDates: 06/01/2015–05/31/2017TotalDollars: $10,000Investigators: PI:Mohs;co-PI:Dr.MichaelBoska

Title: Nanoparticle-BasedDeliveryofNovelFattyAcidSynthaseInhibitors.FundingAgency: WakeForestUniversityHealthSciences&VirginiaTechMechanism: WFUComprehensiveCancerCenter-SchoolofBiomedicalEngineering

andSciencesJointPilotAwardDates: 09/01/2014–08/31/2015TotalDollars: $50,000Investigators: PI:Dr.StevenKridel;co-PI:Mohs,Dr.ToddLowther

Title: OpticalMolecularTomographyforRegenerativeMedicine.FundingAgency: NIH/NHLBIMechanism: BioengineeringResearchPartnership;R01HL098912Dates: 03/01/2010–11/30/2014TotalDollars: $2,852,790Investigators: PI:Dr.GeWang;co-PI:Dr.ShaySoker;co-I:Mohs,Dr.YongXu,etal.

Title: ControlledReleaseBiomaterialsforIL-35SecretingMesenchymalStromalCellsfortheTreatmentofTypeIDiabetes.

Page 5: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

5

FundingAgency: WakeForestInstituteforRegenerativeMedicineMechanism: PromotingInnovativeDiscoveriesPilotDates: 08/01/2014–07/31/2015(approximate)TotalDollars: $25,000Investigators: PI:Mohs;co-PIs:Drs.EmmanuelOpara,ChrisPorada,GracaAlmeida-

Porada

Title: NewNearInfraredImagingMethodtoDetectGeneticallyLabeledCellsUsingaNerve/MuscleConstructModel.

FundingAgency: WakeForestInstituteforRegenerativeMedicine Mechanism: PilotSeedGrantDates: 06/01/2012–05/31/2013(approximate)TotalDollars: $25,000Investigators: PI:Mohs;co-PIs:Drs.KhalilBitar,FrankMarini,RobertGilmont

STUDYSECTIONSNational/International

2017 AdhocMember,MedicalImagingStudySection(MEDI),NIHCenterforScientificReview,Denver,CO

2017 AdHocMember,QEDProgram,reviewadministeredbytheAmericanInstituteforBiologicalSciences

2015 Member,SpecialEmphasisPanel(2015/05ZCA1TCRB-Q(M1)),CentersforCancerNanotechnologyExcellence(CCNE),Bethesda,MD

2015 Reviewer,AppliedandEngineeringResearches,MinistryofScienceandTechnology,StateofIsrael

State

2013–Present ScientificReviewPanel,MarylandStemCellResearchFund,BaltimoreMD

2013 ScientificReviewPanel,NYSTEMProgram,RestonVA

Institutional

2017 Reviewer,GraduateStudentFellowship–CellBio;Chair:Dr.MatthewZimmerman

2016–Present Reviewer,GraduateStudentFellowship–DrugDevelopment;Chair:Dr.RakeshSingh

PATENTSIssuedPatents

Page 6: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

6

1. NieS,MohsAM,ManciniMC,inventors;EmoryUniversity,assignee.Integratedsystemandmethodsforreal-timeanatomicalguidanceinadiagnosticortherapeuticprocedure.UnitedStatespatentUS9,451,882.2016Sept27.

2. NieS,MohsAM,ManciniMC,inventors;EmoryUniversity,assignee.Additionalsystemsandmethodsforprovidingreal-timeanatomicalguidanceinadiagnosticortherapeuticprocedure.UnitedStatespatentUS9,345,389.2016May24.

PendingPatents

1. Mohs AM, Svechkarev D, PayneWM. Tunable fluorescent organic nanoparticles andmethodsofmakingandusingthesame.UnitedStatesprovisionalpatentapplicationUS62/459,082.2017Feb15.

2. MohsAM,HillTK,KridelSJ.FAS InhibitorsandMethodsAssociatedTherewith.UnitedStatesprovisionalpatentapplicationUS15/328,797.2017Jan24.

3. Mohs AM, Kridel SJ. Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-GuidedSurgeryandDrugDeliveryVehiclesandMethodsAssociatedTherewith.UnitedStatesprovisionalpatentapplicationUS15/326,694.2017Jan10.

4. ZongY,LuZR,MohsAM,FengY,inventors;UniversityofUtahassignee.BiodegradablemacromolecularMRIcontrastagentsandmethodsofpreparationandusethereof.UnitedStatesprovisionalpatentapplicationUS60/814,449.2006June16.

ActiveTechnologyDisclosures

1. MohsAM,SvechkarevD,PayneWM.Tunablefluorescentorganicnanoparticles.UNMCref:17015.(Disclosure:September20,2016).

2. MohsAM,SvechkarevD,PayneWM.Polymer-basedStainingandSensingAgents.UNMCref:17014(Disclosure:September20,2016).

CONSULTINGPOSITIONS2014–Present AssociateEditor,FrontiersinPharmacology:IntegrativeandRegenerative

Pharmacology

2011–2012 SeniorScientificConsultant,Spectropath,Inc.,Atlanta,GA

ManuscriptAdHocReviewer(ImpactFactor)

ActaBiomaterialia(6.319)

ACSAppliedMaterialsandInterfaces(7.504)

ACSNano(13.334)

AdvancedDrugDeliveryReviews(15.606)

Page 7: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

7

AdvancedFunctionalMaterials(11.382)

AmericanJournalofRoentgenology(2.731)

Analytical&BioanalyticalChemistry(3.578)

AnalyticalChemistry(5.636)

BioconjugateChemistry(4.513)

Biomaterials(8.387)

ColloidsandSurfacesB:Biointerfaces(4.125)

Endocrine-RelatedCancer(5.267)

EuropeanPolymerJournal(3.242)

IEEETransactionsonBiomedicalEngineering(3.577)

JournalofAppliedPolymerScience(1.600)

JournalBiomedicalApplications(2.082)

JournalofPhotochemistryandPhotobiologyA:Chemistry(2.625)

JournalofMedicinalChemistry(6.259)

MedicalPhysics(2.635)

MolecularPharmaceutics(4.384)

Nanomedicine:Nanotechnology,Biology,andMedicine(6.692)

NatureNanotechnology(35.267)

PharmaceuticalResearch(3.420)

PLOSONE(3.057)

ScientificReports(5.228)

Small(8.315)

TranslationalResearch(4.652)

Theranostics(8.712)

MILITARYSERVICENone.

HONORSANDAWARDS2017 NewInvestigatorAward,UniversityofNebraskaMedicalCenter

Page 8: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

8

2014 WakeForestComprehensiveCancerCenterNominee,Pew-StewartScholarsProgramforCancerResearch

2010 InnovationoftheYear(IntegratedImagingandSpectroscopySystemforImage-GuidedSurgery)–awardedbytheEmoryOfficeofTechnologyTransfer

2006–2011 Emory–GeorgiaTechCenterforCancerNanotechnologyExcellenceDistinguishedFellowship

2006 WolfPrize–awardedtoaUniversityofUtahCollegeofPharmacygraduatestudentforexcellenceinteaching,highestawardgivenbytheCollegeofPharmacy

2006 JeffreyA.FoxAward–awardedtoUniversityofUtah,Pharmaceuticsgraduatestudentfordedicationandservicetodepartment

2005 PhRMAFoundationPredoctoralFellowshipawardedbythePhRMAFoundation,Washington,DC

2005 Vice-Chair,StudentAdvisoryCommittee,PharmaceuticsandPharmaceuticalChemistry,UniversityofUtah

2002 EnzonFellowshipawardedbyEnzonInc.,Pistacaway,NJ

2000 St.John’sUniversityStudyAbroadProgramattheUniversityofSalzburg

1999–2000 SiehlScholarship–awardedbySt.John’sUniversityforacademicexcellenceandleadership

1998–2002 President’sScholarship–awardedbySt.John’sUniversity,basedonacademicachievement,service,andleadership

1998–2002 RecognitionScholarshipforStudentsinScience–awardedbySt.John’sUniversity,basedonacademicachievementinscience

MEMBERSHIPS/OFFICESINPROFESSIONALSOCIETIESMemberships

AmericanAssociationforCancerResearch(AACR)

AmericanAssociationofPharmaceuticalScientists(AAPS)

AmericanChemicalSociety(ACS)

ControlledReleaseSociety(CRS)

WorldMolecularImagingSociety(WMIS)

SocietyandNationalOrganizationServiceContributions

2017 Abstract Reviewer, World Molecular Imaging Congress, WorldMolecularImagingSociety

Page 9: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

9

2016 UNMCAAPSStudentChapterEarly-stageCareerDevelopmentPanelist

2014 Vice-Chair, Regenerative Imaging and SensingWorkingGroup; TissueEngineeringandRegenerativeMedicineInternationalSociety

2012 SessionChair,CancerImaging,BiomedicalEngineeringSocietyAnnualMeeting

2013–2014 Selection Committee Chair, Wake Forest Institute of RegenerativeMedicine Young Investigator Award; Tissue Engineering andRegenerativeMedicineInternationalSociety

2013–2014 Abstract Reviewer, Cancer Technologies, Biomedical EngineeringSocietyAnnualMeeting

2013 Invited Faculty Panelist on Career Development at the BiomaterialsGordonResearchSeminar;Holderness,NH

2013 Abstract Reviewer, Imaging Technologies, Tissue Engineering andRegenerativeMedicineInternationalSociety

2011–2012 Chair, Nanomaterials/NanoformulationsWorking Group, NCI AllianceforNanotechnologyinCancer

2008 Participant, NIST-ASTM sponsored interlaboratory study (ILS) onnanotechnologystandardization

2007–2010 Participant,NCIWorkingGrouptosetstandardsfornanotechnologyasachemicalandbiologicaltechnologyforcancerinformatics,detection,andtreatment

COMMITTEEASSIGNMENTSUniversityofNebraskaMedicalCenter

Nov.2017–Present BioimagingCoreAdvisoryCommittee(Chair.Dr.YutongLiu)

July2016–Present PharmaceuticalSciencesGraduateProgramCommittee(Chair:Dr.JeredGarrison)

June2016–Sept.2016 CollegeofPharmacyBusinessManagerSearchCommittee(Chair:Dr.ChristopherShaffer)

Jan.2016–Present CancerResearchGraduateProgramCommittee(Chair:Dr.JoyceSolheim)

July2015–Present Member,AdmissionsCommittee,UNMCCollegeofPharmacy(co-Chairs:Drs.ChristopherShafferandCharlesKrobot)

WakeForestUniversityHealthSciences

July2013–Mar.2015 BiomedicalEngineeringSociety(BMES)WakeForestStudentChapterFacultyAdvisor

Page 10: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

10

July2012–Mar.2015 WakeForestInstituteforRegenerativeMedicineDepartmentalAnimalCareandUseCommitteeReviewer

Sept.2011–Mar.2015 WakeForest–VirginiaTechSchoolofBiomedicalEngineeringandSciencesFacultysearchcommittee

DoctorofPhilosophyGraduateStudentCommittees

Oct.2017–Present Chair,GraduateCommitteeforMadelineOlsen(UNMC-CRGP);Chair:Dr.AaronMohs

June2016–Present Chair,GraduateCommitteeforBowenQi(UNMC-PSGP);Chair:Dr.AaronMohs

May2016–Present Chair,GraduateCommitteeforNickWojtynek(UNMC-CRGP);Chair:Dr.AaronMohs

Aug.2015–Present Chair,GraduateCommitteeforWilliamPayne(UNMC-PSGP);Chair:Dr.AaronMohs

Aug.2015–Present Chair,GraduateCommitteeforDeepBhattacharya(UNMC-PSGP);Chair:Dr.AaronMohs

May2015–Present Member,GraduateCommitteeforYiChen(UNMC-PSGP);Chair:Dr.DavidOupicky

Aug.2016–Present Member,GraduateCommitteeforYuHang(UNMC-PSGP);Chair:Dr.DavidOupicky

Aug.2014–Present Member,GraduateCommitteeforEllieMcCabe(WFUHS-MolecularMedicine);Chair:Dr.NicoleLevi-Polyachenko(WFUHS)

Aug.2011–June2017 Member,GraduateCommitteeforEtaiSapoznik(WFUHS-BiomedicalEngineering);Chair:Dr.ShaySoker

Feb.2017–May2017 Member,GraduateCommitteforYinnongJai(UNMC-PSGP);Chair:Dr.JeredGarrison

Aug.2012–Dec.2015 Member,GraduateCommitteeforBenjaminRowe(WFUHS-Physiology/Pharmacology);Chair:Dr.GeorgeChrist(WFUHS)

Aug.2012–Aug.2015 Member,GraduateCommitteeforHannahBaker(WFUHS-BiomedicalEngineering);Chair:Dr.GeorgeChrist(WFUHS)

June2012–July2015 Member,GraduateCommitteeforRiuWang(WFUHS-BiomedicalEngineering);Chair.Dr.WilliamWagner(WFUHS)

Page 11: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

11

Aug.2011–May2015 Member,GraduateCommitteeforJohnP.McQuelling(WFUHS-BiomedicalEngineering);Chair:Dr.EmmanuelOpara(WFUHS)

Jan.2012–Apr.2015 Chair,GraduateCommitteeforTannerHill(WFUHS-BiomedicalEngineering);Chair:Dr.AaronMohs(WFUHS)

Jun.2012–Apr.2015 Co-Chair,GraduateCommitteeElizabeth(Graham)Gurysh(WFUHS-BiomedicalEngineering);Chair:Dr.NicoleLevi-Polyachenko(WFUHS),Co-Chair:Dr.AaronMohs(WFUHS)

Aug.2011–Jan.2015 Member,GraduateCommitteeforJohnScott(WFUHS-BiomedicalEngineering);Chair:Dr.GeorgeChrist(WFUHS)

MasterofScienceGraduateStudentCommittees

Aug.2014–Jun.2015 Chair,GraduateCommitteeforWilliamPayne(WFUHS-BiomedicalEngineering);Chair:AaronMohs(WFUHS)

Aug.2011–May.2012 Member,GraduateCommitteeforRiuWang(WFUHS-BiomedicalEngineering);Chair:Dr.WilliamWagner(WFUHS)

PRESENTATIONSInternational,National,andRegionalMeetings

1. MohsAM.Fluorescenthyaluronicacidnanoparticlesenhancepancreaticcancerinmiceforsurgicalnavigation.ContrastMediaResearch;Durango,CO,October2017.

2. MohsAM(Invited).Image-guidedsurgeryusingnearinfraredfluorescentnanoparticles.NanoBioChina2016the1stSymposiumonMinimallyInvasiveandImageGuidedSurgery;Nanjing,China,October2016.

3. MohsAM.Image-guidedsurgeryfortumorremovalusinghyaluronicacid-derivednearinfraredfluorescentnanoparticles.10thWorldBiomaterialsCongress;Montreal,Canada,May2016.

4. MohsAM. IntraoperativeImagingUsingNear InfraredFluorescentHyaluronicAcid.7thAnnualSino-U.S.JointResearchForum;Omaha,NE,May2016.

5. Kelkar SS, Hill TK, Payne WM,Mohs AM. Near Infrared Fluorescent Self-AssembledNanoparticles for Image-Guided Surgery; Materials Research Society Fall Meeting &Exhibit;Boston,MA,December2015.

6. MohsAM,HillTK,KelkarSS,MariniFC,Levine,E.HyaluronicAcidDerivedNanoparticleswithActivatableFluorescenceforImage-GuidedTumorSurgery;BiomedicalEngineeringSocietyAnnualMeeting;SanAntonio,TX,October2014.

Page 12: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

12

7. Mohs AM, Raghavan S, Gilmont R, Somara S, Marini FC, Bitar KN. Near InfraredFluorescent Neural Progenitor Cells to Track Differentiation and Tissue Innervation;BiomedicalEngineeringSocietyAnnualMeeting;SanAntonio,TX,October2014.

8. MohsAM.NanotechnologyforMinimallyInvasiveCancerDetectionandResection;NCIAlliance for Nanotechnology in Cancer InvestigatorsMeeting; Rockville, MD, October2014.

9. Mohs AM. Near Infrared Fluorescent Protein Labeling of Enteric Nerve Cells:Development and Initial Characterization of IM-FEN-iRFP Cells, North Carolina TissueEngineering and RegenerativeMedicine Society AnnualMeeting;Winston-Salem, NC,October2013.

10. Mohs AM. Nanotechnology for Image-Guided Intervention: Potential for ProstateCancer?, Prostate Cancer Research and Translation Symposium; Winston-Salem, NC,March2013.

11. MohsAM,ManciniMC,QianX,WangY,ProvenzaleJM,NieS.NanotechnologyforGuidedTumor Resection, NCI Alliance for Nanotechnology in Cancer Investigators Meeting;Houston,TX,November2012.

12. Mohs AM, Wang Y, Qian X, Mancini MC, Provenzale J, Nie S. Nanotechnology forSpectroscopic and Image-Guided Tumor Resection, Biomedical Engineering SocietyAnnualMeeting;Atlanta,GA,October2012.

13. MohsAM.Tumorcellmarker imaging:searchingforthemicrometastasesthatchangethegame,RSNA/ASTROCancerImagingandRadiationTherapySymposium;Atlanta,GA,April2011(co-presentersProvenzaleJMandManciniMC).

14. MohsAM.Laser-guidedwidefieldimagingandspectroscopyforguidanceduringsurgicalresectionoftumors,FitzpatrickInstituteforPhotonicsAnnualMeeting;DukeUniversity,Durham,NC,October2010(copresentersManciniMC,ProvenzaleJM).

15. MohsAM,ManciniMC,ProvenzaleJM,SinghalS,WangMD,NieS.Ahand-heldimagingand spectroscopy device for intraoperative, contrast-enhanced tumor detection,BiomedicalEngineeringSocietyAnnualMeeting;Austin,TX,October2010.

16. MohsAM,RazaSH,White,WB,KaddiC,ManciniMC,NieS,WangMD,SinghalS.Thedevelopment of a novel endoscope to visualize residual tumor cells following cancersurgery,AmericanCollegeofSurgeons95thAnnualClinicalCongress;Chicago,IL,October2009.

17. Mohs AM, Smith AM, Mancini MC, Wen MM, Nie S. Investigating the Interactions,Consequences,andApplicationsofNanoparticlesatBiologicalInterfaces,NCIAllianceforNanotechnologyinCancerInvestigatorsMeeting;Chicago,IL,September2008.

Page 13: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

13

18. MohsAM,ZongY,GoodrichKC,ParkerDL,LuZR.PEG-g-(GdDTPA-co-L-cystine):effectofPEG chain lengthon in vivo contrast enhancement inMRI,UtahCenter forAdvancedImagingResearch17thAnnualSymposium;SaltLakeCity,UT,October2005.

19. MohsAM,WangX,ZongY,GoodrichKC,ParkerDL,LuZR.PEG-g-(GdDTPA-co-L-cystine):abiodegradablemacromolecularcontrastagentforbloodpoolMRimaging,UtahCenterforAdvancedImagingResearch16thAnnualSymposium;ParkCity,UT,November2004.

InvitedExternalInstitutionPresentations

1. Mohs AM. Surgical imaging using near infrared fluorescence. South Dakota StateUniversity;Brookings,SD,December2017.

2. Mohs AM. Biomedical imaging and nanotechnology: An example of how clinicalchallenges guide scientific innovation. Glen Arth Seminar Series, College of St.Benedict/St.John’sUniversity;St.Joseph,MN,November2016.

3. Mohs AM. Contrast-enhanced fluorescence for intraoperative imaging. Frank ReidyResearchCenterforBioelectrics(FRRCBE),OldDominionUniversity;Norfolk,VA,October2016.

4. MohsAM.Hyaluronan-derivednanoparticlesforbiomedicalapplications:Experiencesinimaging and drug delivery. China Pharmaceutical University; Nanjing, China, October2016.

5. MohsAM. The Role of CancerNanotechnology for Intraoperative Imaging, College ofEngineering,UniversityofNebraskaatLincoln;Lincoln,NE,April2016.

6. MohsAM.CancerNanotechnology:ApplicationsforImage-GuidedSurgery;DepartmentofChemistry,UniversityofNebraskaatOmaha;Omaha,NE,April2016.

7. MohsAM.NanotechnologyforContrast-EnhancedFluorescence-GuidedSurgery;LI-CORBiosciences;Lincoln,NE,December2015.

8. MohsAM.Nanotechnology for Image-GuidedTumorSurgery;BiomedicalEngineering,UniversityofSouthDakota;SiouxFalls,SD,September2014.

9. MohsAM.HyaluronicAcidDerivedNanoparticles for Image-GuidedSurgery andDrugDelivery;Chemistry,WakeForestUniversity;Winston-Salem,NC,September2014.

10. Mohs AM. Nanotechnology for Emerging Biomedical Applications, Joint School forNanoscience andNanoengineering atUNCGreensboro andNCA&T,Greensboro,NC,November2012.

11. MohsAM.Nanotechnologyformedicalandsurgicalimaging:currentstatusandfuturepossibilities, Duke Radiology Grand Rounds; Durham, NC, January 2011 (co-presenterProvenzaleJM).

Page 14: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

14

12. Mohs AM.Wide-field optical imagingwith interactive excitation and spectroscopy toresectcontrast-enhancedtumors,NortheasternUniversity;Boston,MA,January2011.

13. MohsAM.Wide-fieldopticalimagingusingpointexcitationandspectroscopyforimage-guidedresectionofcontrast-enhancedtumors,UTSouthwesternMedicalCenter;Dallas,TX,November2010.

14. MohsAM.Quantumdotsforcellularandmolecularimaging:unusualopticalpropertiesandcellulartoxicity,InvitedspeakeratUTDallas;Richardson,TX,November2010.

15. MohsAM.IntegratedSpectroscopyandImagingforIntraoperativeCancerDetectionandSurgicalOncology,CaseWesternReserveUniversity;Cleveland,OH,January2010.

InvitedInternalPresentations

1. MohsAM.Multimodalcontrastagentsforintegratedpreoperativeandintaoperativeimagingofpancreaticcancer.PancreaticSPOREExternalAdvisoryBoardMeeting;Omaha,NE,November2017.

2. MohsAM.Theversatilityofhyaluronicacidasatherapeuticandimagingagentdeliveryvehicle.CancerGenes&MolecularRegulationProgram(CGMRP),BuffettCancerCenter;Omaha,NE,September2017.

3. MohsAM.NanoparticleformulationsofOrlistatfortreatmentofchemoresistantcancer:anupdate.COBREExternalAdvisoryBoardMeeting;Omaha,NE,July2017.

4. MohsAM.Nanoparticle-baseddetectiontechnology.AirForceSurgeonGeneralAcquisitionStaff;Omaha,NE,July2017

5. MohsAM.Applicationsofmodifiedpolysaccharides:Experiencesinintraoperativeimaginganddrugdiscovery,BiochemistryandMolecularBiologySeminarSeries,UNMC;Omaha,NE,February2017.

6. MohsAM.Multimodalitycontrastagentdevelopment:Potentialforpancreaticcancer.UNMCPancreaticSPOREMeeting;Omaha,NE,August2016.

7. MohsAM.Image-guidedsurgery:Investigationsattheinterfaceofscience,medicine,andengineering.MD-PhDScholarsProgramInvitedSeminar;Omaha,NE,June2016.

8. MohsAM.NanoparticleformulationsofOrlistatfortreatmentofchemoresistantcancer.COBRERetreat;NebraskaCity,NE,June2016.

9. MohsAM.SurgicalGuidanceUsingNearInfraredFluorescence;InvitedSeminar;GenitourinaryOncologyFocusGroup,UniversityofNebraskaMedicalCenter;Omaha,NE,April2016.

10. MohsAM.NanoparticleFormulationsofnearinfrareddyesforimage-guidedsurgery.SurgeryResearchForum,Omaha,NE,March2016.

COMMUNITYSERVICE/OUTREACH

Page 15: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

15

2012 Sciencefairevaluator-SherwoodForestElementary(Winston-Salem,NC)

PUBLICATIONSA) PublishedJournalArticles(oldesttonewest)1. MohsAM,WangX,GoodrichKC, ZongY, ParkerDL, Lu Z-R. PEG-g-poly(GdDTPA-co-L-

cystine): a biodegradablemacromolecular blood pool contrast agent forMR imaging.BioconjugChem.2004;15(6):1424–30.PMID:15546211

2. MohsAM,ZongY,GuoJ,ParkerDL,LuZ-R.PEG-g-poly(GdDTPA-co-L-cystine):effectofPEG chain length on in vivo contrast enhancement in MRI. Biomacromolecules.2005;6(4):2305–11.PMID:16004476

3. ZongY,WangX,GoodrichKC,MohsAM,ParkerDL,LuZ-R.Contrast-enhancedMRIwithnew biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.MagnResonMed.2005;53(4):835–42.PMID:15799038

4. Lu Z-R, Mohs AM, Zong Y, Feng Y. Polydisulfide Gd(III) chelates as biodegradablemacromolecular magnetic resonance imaging contrast agents. Int J Nanomedicine.2006;1(1):31–40.PMID:17722260

5. Zong Y, Guo J, Ke T, Mohs AM, Parker DL, Lu Z-R. Effect of size and charge onpharmacokineticsandinvivoMRIcontrastenhancementofbiodegradablepolydisulfideGd(III)complexes.JControlRelease.2006;112(3):350–6.PMID:16631270

6. MohsAM,NguyenT,JeongE-K,FengY,EmersonL,ZongY,ParkerDL,LuZ-R.ModificationofGd-DTPA cystine copolymerswithPEG-1000optimizespharmacokinetics and tissueretention for magnetic resonance angiography.Magn Reson Med. 2007;58(1):110–8.PMID:17659618

7. Mohs AM, Lu Z-R. Gadolinium(III)-based blood-pool contrast agents for magneticresonanceimaging:statusandclinicalpotential.ExpertOpinDrugDeliv.2007;4(2):149–64.PMID:17335412

8. FengY,JeongE-K,MohsAM,EmersonL,LuZ-R.Characterizationoftumorangiogenesiswith dynamic contrast-enhanced MRI and biodegradable macromolecular contrastagentsinmice.MagnResonMed.2008;60(6):1347–52.PMID:19025902

9. SmithAM,DuanH,MohsAM,NieS.Bioconjugatedquantumdotsforinvivomolecularandcellularimaging.AdvDrugDelivRev.2008;60(11):1226–40.PMID:18495291

10. Smith AM,Mohs AM, Nie S. Tuning the optical and electronic properties of colloidalnanocrystalsbylatticestrain.NatNanotechnol.2009;4(1):56–63.PMID:19119284

11. MohsAM,DuanH,KairdolfBA,SmithAM,NieS.Proton-resistantquantumdots:stability

Page 16: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

16

ingastrointestinalfluidsandimplicationsfororaldeliveryofnanoparticleagents.NanoRes.2009;2(6):500–508.PMID:20379372

12. MohsAM, Provenzale JM. Applications of nanotechnology to imaging and therapy ofbraintumors.NeuroimagingClinNAm.2010;20(3):283–92.PMID:20708547

13. MohsAM,ManciniMC,SinghalS,ProvenzaleJM,Leyland-JonesB,WangMD,NieS.Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrastenhancement, detection sensitivity, and tissue penetration. Anal Chem.2010;82(21):9058–65.PMID:20925393

14. Provenzale JM, Mohs AM. Nanotechnology in neurology-current status and futurepossibilities.USNeurol.2010;6(1):12–17.

15. BennettJR,OpieAMT,XuQ,YuH,WalshM,ButlerA,ButlerP,CaoG,MohsA,WangG.Hybridspectralmicro-CT:systemdesign,implementation,andpreliminaryresults. IEEETransBiomedEng.2014;61(2):246–53.PMID:23996533

16. OpieAMT,BennettJR,WalshM,RajendranK,YuH,XuQ,ButlerA,ButlerP,CaoG,MohsAM,WangG.Studyofscanprotocolforexposurereductioninhybridspectralmicro-CT.Scanning.2014;36(4):444–55.PMID:24604215

17. MohsAM*,ManciniMC,Provenzale JM, SabaCF,Cornell KK,HowerthEW,Nie S.Anintegrated widefield imaging and spectroscopy system for contrast-enhanced, image-guided resection of tumors. IEEE Trans Biomed Eng. 2015;62(5):1416–1424. PMID:25585410.*Denotescorrespondingauthor.

18. HillTK,AbdulahadA,KelkarSS,MariniFC,LongTE,ProvenzaleJM,MohsAM.Indocyaninegreen-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem.2015;26(2):294–303.PMID:25565445

19. Stevenson AT, Reese LM, Hill TK, McGuire J, Mohs AM, Shekhar R, Bickford LR,Whittington AR. Fabrication and characterization of medical grade polyurethanecomposite catheters for near-infrared imaging. Biomaterials. 2015;54:168–76. PMID:25907050

20. NiuG,SapoznikE,LuP,CriswellT,MohsAM,WangG,LeeS-J,XuY,SokerS.Fluorescentimagingofendothelialcellsinbioengineeredbloodvessels:theimpactofcrosslinkingofthescaffold.JTissueEngRegenMed.2016;10(11):955–966.PMID:24616385

21. Hill TK,Mohs AM. Image-guided tumor surgery: will there be a role for fluorescentnanoparticles?WIREsNanomedNanobiotechnol.2016;8(4):498–511.PMID:26585556

22. HillTK,DavisAL,WheelerFB,KelkarSS,FreundEC,LowtherWT,KridelSJ,MohsAM.DevelopmentofaSelf-AssembledNanoparticleFormulationofOrlistat,Nano-ORL,withIncreasedCytotoxicityagainstHumanTumorCellLines.MolPharm.2016;13(3):720–8.

Page 17: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

17

PMID:26824142

23. KelkarSS,HillTK,MariniFC,MohsAM.Nearinfraredfluorescentnanoparticlesbasedonhyaluronic acid: Self-assembly, optical properties, and cell interaction.Acta Biomater.2016;36:112–21.PMID:26995504

24. YoonY,MohsAM,ManciniMC,NieS,ShimH.Combinationofanintegrin-targetingNIRtracerandanultrasensitivespectroscopicdeviceforintraoperativedetectionofheadandneck tumor margins and metastatic lymph nodes. Tomography. 2016;2(3):215–222.PMID:27738656

25. HillTK,KelkarSS,WojtynekNE,SouchekJJ,PayneWM,StumpfK,MariniFC,MohsAM.Near infrared fluorescent nanoparticles derived from hyaluronic acid improve tumorcontrast for image-Guided surgery. Theranostics. 2016;6(13):2314–2328. PMID:27877237

26. ZarifpourM,AnderssonK-E,KelkarSS,MohsA,MendelsohnC,SchneiderK,MariniF,ChristGJ.Characterizationofamurinemodelofbioequivalentbladderwoundhealingand repair followingsubtotal cystectomy.BioresOpenAccess.2017;6(1):35–45.PMID:28560089

27. SouchekJJ,DavisAL,HillTK,HolmesMB,QiB,SinghPK,KridelSJ,MohsAM.Combinationtreatmentwithorlistat-containingnanoparticlesandtaxanesissynergisticandenhancesmicrotubule stability in taxane-resistant prostate cancer cells.Mol Cancer Ther.2017;16(9):1819-1830.PMID:28615298

28. PayneWM,HillTK,SvechkarevD,HolmesMB,SajjaB,MohsAM.Multimodal imagingnanoparticles derived from hyaluronic acid for integrated preoperative andintraoperativecancer imaging.ContrastMediaMol Imaging.2017;Article ID9616791.PMID:29097944

29. BhattacharyaD,SvechkarevD,SouchekJJ,HillTK,TaylorMA,NatarajanA,MohsAM.ImpactofstructurallymodifyinghyaluronicacidonCD44interaction.JMaterChemB.2017;5(41):8183-8192.

30. BogdanD,SvechkarevD,ArnulfR,TromayerM,LiskaR,MohsAM,VautheyE.Directobservationofaphotochemicalalkyne-allenereactionandofatwistedandrehybridizedintramolecularcharge-transferstateinadonor-acceptordyad.J.Am.Chem.Soc.2017;139(46):16885-16893.

31. SvechkarevD,KyrychenkoA,PayneWM,MohsAM.Developmentofcolloidallystablecarbazole-basedfluorescentnanoaggregates.J.Photochem.PhotobiolA.2018;352:55-64.

Page 18: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

18

32. PayneWM,SvechkarevD,KyrychenkoA,MohsAM.Theroleofhydrophobicmodificationhyaluronicaciddynamicsandself-assembly.CarbohydrPolym.2018;182:132-141.

B) ArticlesAcceptedforPublicationNone.

C) ArticlesSubmittedforPublication1. QiB,CrawfordAJ,WojtynekNE,HolmesMB,SouchekJJ,Almeida-PoradaG,LyQP,Cohen

SM, Hollingsworth MA, Mohs AM. Indocyanine green loaded hyaluronan-derivednanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer.SubmittedtoNanomedicineonAugust14,2017(RevisionUnderReview).

2. GuryshE,KelkarS,McCabe-LankfordE,KuthirummalN,BrownT,KockN,MohsAM,Levi-PolyachenkoN.Hybriddonor-acceptorpolymerparticleswithamplifiedenergytransferfor detection andon-demand treatment of breast cancer. Submitted toACSNano onOctober23,2017.

3. SvechkarevD,MohsAM.Organicfluorescentdye-basednanomaterials:Advancesintherationaldesign for imagingand sensingapplications. Submitted toCurrMedChemonNovember6,2017(RevisionUnderReview).

D) BooksPublishedNone.

E) ChaptersinBooks1. KelkarSS,MohsAM.TranslationalImagingforRegenerativeMedicine.InTranslational

RegenerativeMedicine;AtalaA,AllicksonJ,Eds.;AcademicPress:Elsevier:Waltham,MA,2015;pp257-265.

F) BooksorJournalsEdited

None.

G) MediaFeatures

RelatedtomansucriptMohsAM,etal.AnalChem.2010;82(21):9058–65.PMID:20925393.

Chemical&EngineeringNews,October15,2010. Optics&PhotonicsNews,January1,2011

RelatedtomanuscriptMohsAM,etal.IEEETransBiomedEng.2015;62(5):1416–1424.PMID:25585410.

IEEETransBiomedEngCoverandFeaturearticle.ScienceDaily,January20,2015.PhotonicOnline,January20,2015.

Page 19: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

19

WSJSMohsRadioInterview.

H) AbstractsandPreliminaryCommunications(10of49;presenterunderlined)

1. Svechkarev D, Kyrychenko A, Payne WM, Mohs AM. Tunable fluorescent organicnanoparticles for cancer imaging applications. NCI Innovative Molecular AnalysisTechnologiesAnnualPIMeeting;Rockville,MD,December2017.Poster.

2. Qi B, Crawford AJ, Holmes MB, Wojtynek NE, Souchek JJ, Almeida-Porada G,Hollingsworth MA, Mohs AM. Indocyanine green loaded hyaluronan-derivednanoparticles for fluorescence-enhanced surgical imaging of an orthotopic pancreaticcancer model. World Molecular Imaging Congress; Philadelphia, PA, September2017.PodiumPresentation.

3. Svechkarev D, Payne WM, Mohs AM. Colloidal stability and spectral properties ofcarbazole-based fluorescent nanoaggregates. 17th IEEE International Conference onNanotechnology;Pittsburgh,PA,July2017.Poster.

4. PayneWM,SvechkarevD,KyrychenkoA,MohsAM.Computationalmodelsofpolymericnanoparticlesforrationaldesignindrugdelivery.GordonResearchConferenceonCancerNanomedicine;MountSnow,VT,June2017.Poster.*SelectedforPodiumPresentation.

5. BhattacharyaDS,SvechkarevD,Souchek JJ,Hill TK,TaylorM,NatarajanA,MohsAM.TuninghyaluronicacidbindingpropertiestoCD44usingsynthetic, invitroandinsilicoapproaches. 253rd American Chemical Society National Meeting and Exposition; SanFrancisco,CA,April2017.Poster.

6. HillTK,KelkarSS,SouchekJJ,PayneWM,MariniFC,MohsAM.Nearinfraredhyaluronan-derived nanoparticles for fluorescence image-guided tumor surgery. Imaging in 2020;JacksonHole,WY,September2016.Poster.

7. SouchekJJ,HillTK,DavisAL,QiB,HolmesMB,SinghPK,KridelSJ,MohsAM.Combinationtreatment with Nano-Orlistat and taxanes is synergistic and enhances microtubulestability in taxane-resistant prostate cancer cells. 14th International Nanomedicine &DrugDeliverySymposium(NanoDDS);Baltimore,MD,September2016.Poster.*Selectedfor “Rapid Fire Presentation” and awarded Society for Biomaterials-Drug DeliverySpecialInterestGroupResearchAward

8. Payne WM, Svechkarev DA, Boska MD, Mohs AM. Multimodal contrast agents forintegrated preoperative and intraoperative cancer imaging. AACR Engineering andPhysicalSciencesinOncology;Boston,MA,June2016.Poster.

9. SouchekJJ,HillTK,DavisAL,QiB,SinghPK,KridelSJ,MohsAM.Nano-orlistatsynergizeswithtaxanesintaxane-resistantprostatecancercells.7thAnnualSino-U.S.JointResearchSymposium,May2016,UNMC,Omaha,NE.Poster.*FirstPlacePosterPresentationandCashprize.

Page 20: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

20

10. HillTK,AbdulahadA,KelkarSS,MariniFC,LongTE,ProvenzaleJM,MohsAM.Indocyaninegreen-loadednanoparticlesimprovetumorcontrastforimage-guidedsurgery.NanoDDS;Seattle,WA,September2015.Poster.

I. PublishedContinuingEducationMaterials

None.

TEACHINGACTIVITIESA. DidacticCoursework

UniversityofNebraskaMedicalCenter(Sept.2015–May2017)

Course(Role): PharmaceuticalSciencesI,PHSC570(Instructor) Duties: Preparedandpresentedlecturesrelatedtomicromeritics.LecturesGiven: 3

Course(Role): PharmaceuticalSciencesII,PHSC670(Instructor) Duties: Preparedandpresentedlecturesrelatedtozeroandfirst-orderrate

equations,compartmentmodeling,andphysiologically-basedpharmacokinetics.

LecturesGiven: 24

Course(Role): PharmaceuticalSciencesIII,PHSC672(Instructor) Duties: Preparedandpresentedlecturesrelatedtotheconceptsandmodeling

ofpharmacokinetic-pharmacodynamicrelationshipsandmodifiedreleasepharmacokinetics.

LecturesGiven: 10

Course(Role): PharmaceuticalScienceApplicationsinPharmacy,PHSC691(Instructor)

Duties: Preparedandgavelectureonnanotechnologyforimage-guidedsurgery

LecturesGiven: 3

Course(Role): PharmaceuticalsSciencesGraduateProgramSeminar,PHSC970(Co-Coordinator)

Duties: Scheduledseminarsandorganizedtheitineraryofinvitedspeakers;maintainedstudentattendance

Non-lecturehours: 80

WakeForestUniversityHealthSciences(Sept.2011–March2015)

Course(Role): QuantitateOrganSystemsPhysiology,BMES606(CourseDirector,Instructor)

Page 21: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

21

Duties: Arrangedschedulestointegratemathematicalmodeling,simulation,quantitativedescriptionoforganphysiologyandcontrol,andsupervisesemesterproject.

LecturesGiven: 27Non-lecturehours: 90

Course(Role): MedicalImagingII,BMES751(Instructor)Duties: Preparedandgavelecturesonthechemistryofcontrastagentsand

principlesofcontrastenhancedmagneticresonanceimagingandcomputedtomography.

LecturesGiven: 4

Course(Role): DrugDiscovery,DesignandDevelopment,CHM740(Instructor) Duties: Preparedandgavelecturestointroducepharmaceuticalsciencesto

chemistryundergraduateandgraduatestudents,includingadsorption,distribution,metabolism,excretion,andcontrolledrelease.

LecturesGiven: 4

Course(Role): IntroductiontoRegenerativeMedicine,BMES631(Instructor)Duties: Preparedandgavelectureondrugdeliveryintissueengineeringand

regenerativemedicine.LecturesGiven: 1

Course(Role): EngineeringApproachestoTreatingCancer,BMES5984(Instructor)Duties: Preparedagavealectureonusingnanotechnologyfordetecting,

diagnosing,andtreatingcancerLecturesGiven: 1

Course(Role): TopicsinCancerBiology,MCB723(Instructor) Duties: Preparedandgavelectureoncancerimaging.LecturesGiven: 1

B. TeachingRelatedtoUndergraduate/Graduate/PostdoctoralResearchersStudent: WilliamPayne–GraduateStudent

2017-2018BlueWatersGraduateFellowship(6awardednationally);2017UNMCgraduatestudentofdistinction

Program: PharmaceuticalSciences(UNMC);MSBiomedicalEngineering(WFUHS)

Student: DeepS.Bhattacharya–GraduateStudent 2017-2019ProgramofExcellenceAssistantshipRecipientProgram: PharmaceuticalSciences(UNMC)

Student: BowenQi–GraduateStudentProgram: PharmaceuticalSciences(UNMC)

Page 22: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

22

Student: NicholasWojtynek–GraduateStudentProgram: CancerResearch(UNMC)

Student: MadelineOlsen–GraduateStudentProgram: CancerResearch(UNMC)

Student: TannerHill–GraduateStudent,PostdoctoralFellow2014-2015MikeandLucyRobbinsFellowshipAward(WakeForest)foracademic,research,andleadershipexcellence

Program: BiomedicalEngineering(WFUHSasgraduatestudent);PharmaceuticalSciences(UNMCaspostdoctoralfellow)

Student: DenisSvechkarev,PhD–PostdoctoralFellowProgram: PharmaceuticalSciences

Student: JoshuaSouchek,PhD–PostdoctoralFellowProgram: PharmaceuticalSciences

Student: JoeGeraldJesuRaj,PhD–PostdoctoralFellowProgram: PharmaceuticalSciences

Student: SnehaKelkar,PhD–PostdoctoralFellowProgram: BiomedicalEngineering

Student: NoahReed–UndergraduateStudentProgram: UNMCSummerUndergraduateResearchProgram(attendsUniversityof

NebraskaatLincoln)

Student: ChaojunWang–UndergraduateStudentProgram: AsiaPacificRimDevelopmentProgram(attendedXi'anJiaotong

UniversityHealthScienceCenter,China)

Student: EricaFreund–UndergraduateStudentProgram: PhysicsHonorsThesisAdvisor(attendedWakeForestUniversity)

Student: GillianLloyd–UndergraduateStudentProgram: UndergraduateTrainee(attendedWakeForestUniversity,Major:

Biology)

Student: JoshuaCopus–UndergraduateStudentProgram: WakeForestInstituteforRegenerativeMedicineSummerScholar

(attendedClemsonUniversity,Major:BiomedicalEngineering)

Student: XiangxiGao–UndergraduateStudentProgram: WakeForest–VirginiaTechBiomedicalEngineeringSummerScholar

(attendedEmoryUniversity,Major:Math,Biology)

Page 23: Aaron Michael Mohs, Ph.D. 12, 2017 1 Aaron Michael Mohs, Ph.D. Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center

December12,2017

23

Student: KindellSchmitt–UndergraduateStudentProgram: WakeForest–VirginiaTechBiomedicalEngineeringSummerScholar

(attendedVirginiaTech,Major:BiologicalSystemsEngineering)

Student: MarthaKahlson–UndergraduateStudentProgram: WakeForestInstituteforRegenerativeMedicineSummerScholar

(attendedMountHolyokeCollege,Major:Biochemistry)

Student: RobertJohnson,II–UndergraduateStudent Program: NHLBIExcellenceinCardiovascularSciencesProgram(attendedJohnson

C.SmithUniversity,Major:Biology)

Student: FlorenceMcCarty–UndergraduateStudentProgram: NHLBIExcellenceinCardiovascularSciencesProgram(attendedJohnson

C.SmithUniversity,Major:Biology)